Mentha G, Meyer P, Huber O, Le Coultre C, Villiger A, Cereda J M, Widmann J J, Pittet D, Gunn-Séchehaye A, Schneider P A
Département de chirurgie, Hôpital cantonal universitaire, Genève.
Schweiz Med Wochenschr. 1990 Jul 21;120(29):1037-44.
Between July 1987 and May 1989, 11 liver transplants were performed on 10 patients at the University Hospital of Geneva. Of 15 patients evaluated for elective transplantation, 10 were accepted and put on the waiting list. 5 patients were rejected because of a contraindication or because another treatment seemed preferable. 8 transplantations were eventually performed. Emergency transplantation was considered for 6 patients, but could be performed in only 3. Indications for transplantation were as follows: one hepatocellular carcinoma in a non-cirrhotic patient, 2 post-hepatitis cirrhoses (one B and one non-A-, non-B), 3 primary biliary cirrhoses, one autoimmune cirrhosis, one primary sclerosing cholangitis, one cirrhosis on alpha-1-antitrypsin deficiency, and one fulminant B-Delta hepatitis. Most of these patients had advanced liver disease and a limited life expectancy. 8 of the 10 patients transplanted are nevertheless alive and none is hospitalized at the present time. More than mere survival, however, quality of life regained after transplantation prompts us to consider transplantation early in the progress of the disease. Earlier evaluation of patients would make transplantation feasible soon after the first complication of the disease. This attitude would probably prevent patients from dying while on a waiting list and decrease operative as well as early postoperative risks. Better information and coordination regarding potential donors is necessary in Switzerland to obtain better results in organ transplantation.
1987年7月至1989年5月期间,日内瓦大学医院为10名患者实施了11例肝脏移植手术。在接受择期移植评估的15名患者中,10名被接受并列入等待名单。5名患者因存在禁忌证或因其他治疗方法似乎更为可取而被拒绝。最终进行了8例移植手术。6名患者被考虑进行紧急移植,但仅3例得以实施。移植的适应证如下:1例非肝硬化患者的肝细胞癌,2例肝炎后肝硬化(1例乙型肝炎和1例非甲非乙型肝炎),3例原发性胆汁性肝硬化,1例自身免疫性肝硬化,1例原发性硬化性胆管炎,1例α-1抗胰蛋白酶缺乏症所致肝硬化,以及1例暴发性乙型-δ型肝炎。这些患者大多患有晚期肝病,预期寿命有限。然而,10例接受移植的患者中有8例仍存活,目前均未住院。然而,移植后不仅是单纯的存活,生活质量的恢复促使我们在疾病进展早期就考虑移植。对患者进行更早的评估将使在疾病首次出现并发症后不久进行移植成为可能。这种态度可能会防止患者在等待名单上死亡,并降低手术及术后早期风险。在瑞士,有必要就潜在供体提供更好的信息并进行更好的协调,以在器官移植方面取得更好的结果。